Clik here to view.
日本基于智能手机的眼科诊断医疗设备初创公司OUI Inc.荣获AEA2022创新奖冠军
日本千叶 (美国商业资讯)–2022年亚洲创业奖活动(AEA2022)于10月26日（周三）至10月27日（周四）全部在线举行，来自亚洲国家和地区的24家入围科技初创企业参加了比赛。在参与竞争的企业中，日本的OUI Inc.荣获冠军。这家公司开发了一款名为智能眼相机(SEC)的基于智能手机的医疗设备，可以随时随地由任何人执行眼科诊断。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
BeiGene to Present at Upcoming Investor Conferences
CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced that the Company will participate in two...
View ArticleClik here to view.
REGiMMUNE to Present Results from the Phase 2b Study of RGI-2001 at the 2022...
TAIPEI, Taiwan REGiMMUNE Limited, a clinical-stage biopharmaceutical company focused on creating innovative immunotherapies for immune disorders and cancer, today announced that the Phase 2b...
View ArticleClik here to view.
OliX Pharmaceuticals Announces Positive Preclinical Data in NASH Non-human...
SUWON, South Korea OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, announced today that the Company has secured positive effects of OLX702A, an investigational...
View ArticleClik here to view.
MaaT Pharma Announces Participation in Scientific and Investor Conferences in...
LYON, France Regulatory News: MaaT Pharma (EURONEXT: MAAT – the “Company”), a French clinical-stage biotech and a pioneer in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to...
View ArticleClik here to view.
EdiGene Biotechnology Moves into New R＆D Center at Waltham, Mass. to Advance...
BEIJING & WALTHAM, Mass. EdiGene, Inc., a global, clinical-stage company focused on translating its gene-editing technologies into transformative genetic medicines for patients with significant...
View ArticleClik here to view.
10 Studies on Orelabrutinib Selected at the Upcoming 64th Annual Meeting of ASH
BEIJING InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that 10 studies on the BTK...
View ArticleClik here to view.
SnapLogic Powers Abano Healthcare’s Journey to Modernisation
SYDNEY, Australia Abano Healthcare, Australasia’s largest dental support organisation (DSO), leverages SnapLogic, a leader in intelligent integration and enterprise automation, to power its...
View ArticleClik here to view.
Turnstone Biologics to Present Preclinical Data From Novel TIL Therapy...
SAN DIEGO Turnstone Biologics Corp, a clinical-stage biotechnology company developing next-generation immunotherapies to treat and cure solid tumors, today announced that two posters showing...
View ArticleClik here to view.
レビタスバイオがシリーズC資金調達を完了
米カリフォルニア州メンロパーク （ビジネスワイヤ） — ライフサイエンス市場にエンドツーエンドの試料処理・分析サービスを提供する一流企業のレビタスバイオ（www.levitasbio.com）は、業界をリードする強力な細胞分析法を提供するという使命を推進するため、シリーズCラウンドで3500万ドルの資金調達を完了したと発表しました。...
View ArticleClik here to view.
LevitasBio完成C轮融资
加州门洛帕克 (美国商业资讯)–为生命科学市场提供端到端样本处理和分析服务的领先公司LevitasBio, Inc. (www.levitasbio.com)宣布，其已完成C轮3500万美元的融资，用以推进其提供强大的行业领先细胞分析技术的使命。...
View ArticleClik here to view.
エクセンシアが2022年第3四半期の財務業績を2022年11月15日に発表
英オックスフォード （ビジネスワイヤ） — エクセンシア（Nasdaq：EXAI）は、2022年9月30日に終了した第3四半期の財務業績を2022年11月15日（火）の米国市場の開場前に発表します。午後1時30分（GMT）／午前8時30分（米東部時間）から、当社は電話会議とウェブキャストを実施し、事業の最新情報と財務業績について説明します。...
View ArticleClik here to view.
Exscientia将于2022年11月15日公布2022年第三季度业绩
英格兰牛津 (美国商业资讯)–Exscientia plc (Nasdaq: EXAI)将于2022年11月15日（周二）美国市场开盘前公布截至2022年9月30日的第三季度财务业绩。公司将于格林尼治标准时间下午1:30/美国东部标准时间上午8:30举行电话会议和网络直播，介绍最新业务情况并回顾财务业绩。...
View ArticleClik here to view.
World First Dual Wave RF Micro-needling System: Sylfirm X is Recognized by...
SEOUL, South Korea VIOL Co., Ltd hosted the first global event called “Moonlight Sylfirm X Global Symposium 2022” on September 18th, at the Grand Mercure Hotel, Seoul. The Symposium invited renowned...
View ArticleClik here to view.
Guided Therapeutics Provides Update of Significant Progress in Chinese...
PEACHTREE CORNERS, Ga. Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, based on its patented biophotonic technology, announced today that the clinical trial...
View ArticleClik here to view.
BeiGene Announces Brazil Approvals for BRUKINSA® As a Treatment for Rare...
CAMBRIDGE, Mass., & BASEL, Switzerland & BEIJING BeiGene, (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology, today announced BRUKINSA (zanubrutinib) has been approved in...
View ArticleClik here to view.
TAE Life Sciences Announces Partnership with HDX Corporation for Launch of...
FOOTHILL RANCH, Calif. TAE Life Sciences (TLS), a biological-targeted radiation therapy company developing next-generation boron neutron capture therapy (BNCT), today announced a partnership with...
View ArticleClik here to view.
Lemonex, IVI Exchange MOU on Joint Vaccine Development
SEOUL, South Korea The International Vaccine Institute (IVI) announced on November 10th it signed a memorandum of understanding (MOU) with Lemonex, a company specializing in RNA gene therapy...
View ArticleClik here to view.
Kirin Holdings and Kao Begin Joint Research On The Relationship Between...
TOKYO Kirin Holdings Company, Limited (Kirin Holdings) and Kao Corporation (Kao) will participate in the “Wakayama Health Promotion Study” cohort study*1 led by Wakayama Medical University and...
View ArticleClik here to view.
European Commission (EC) Approves LIVTENCITYTM▼ (maribavir) for the Treatment...
OSAKA, Japan & CAMBRIDGE, Mass. Takeda (TSE:4502/NYSE:TAK) today announced that the European Commission (EC) has granted Marketing Authorization for LIVTENCITYTM (maribavir) for the treatment of...
View Article